These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7015394)

  • 1. Efficacy of desipramine in mildly depressed patients: a double-blind, placebo-controlled trial [proceedings].
    Stewart JW; Quitkin F; Liebowitz MR; McGrath PJ; Klein DF
    Psychopharmacol Bull; 1981 Jan; 17(1):136-8. PubMed ID: 7015394
    [No Abstract]   [Full Text] [Related]  

  • 2. Crossover study of zimelidine and desipramine in depression: evidence for amine specificity [proceedings].
    Potter WZ; Calil HM; Extein I; Muscettola G; Goodwin FK
    Psychopharmacol Bull; 1981 Jan; 17(1):26-9. PubMed ID: 6453356
    [No Abstract]   [Full Text] [Related]  

  • 3. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer.
    Holland JC; Romano SJ; Heiligenstein JH; Tepner RG; Wilson MG
    Psychooncology; 1998; 7(4):291-300. PubMed ID: 9741068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desipramine plasma levels and clinical response: evidence for a curvilinear relationship.
    Coryell W; Turner RD; Sherman A
    J Clin Psychopharmacol; 1987 Jun; 7(3):138-42. PubMed ID: 3298326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of desipramine in depressed outpatients. Response according to research diagnosis criteria diagnoses and severity of illness.
    Stewart JW; Quitkin FM; Liebowitz MR; McGrath PJ; Harrison WM; Klein DF
    Arch Gen Psychiatry; 1983 Feb; 40(2):202-7. PubMed ID: 6337580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a norepinephrine uptake inhibitor, in endogenous depression: clinical and biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Adv Biochem Psychopharmacol; 1984; 39():439-47. PubMed ID: 6205564
    [No Abstract]   [Full Text] [Related]  

  • 7. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary results of a double-blind study between rolipram and desipramine in hospitalized patients with major depressive symptoms].
    Guiot-Goffioul F; Gerard-Vandenhove MA; Troisfontaines B; Breulet M; von Frenckell R; Bobon D
    Acta Psychiatr Belg; 1987; 87(2):230-5. PubMed ID: 3618273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.
    McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E
    Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating bulimia with desipramine. A double-blind, placebo-controlled study.
    Hughes PL; Wells LA; Cunningham CJ; Ilstrup DM
    Arch Gen Psychiatry; 1986 Feb; 43(2):182-6. PubMed ID: 3511878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
    Mallinckrodt CH; Watkin JG; Liu C; Wohlreich MM; Raskin J
    BMC Psychiatry; 2005 Jan; 5():1. PubMed ID: 15631624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical experience with clomipramine (Hydiphen) and desipramine (Petytyl) by parenteral administration in the treatment of endogenous depression with signs of pharmacoresistance].
    Cesková E; Náhunek K; Rysánek R; Svestka J
    Cesk Psychiatr; 1983 Apr; 79(2):94-101. PubMed ID: 6345009
    [No Abstract]   [Full Text] [Related]  

  • 13. Double-blind comparison of desipramine and placebo for treatment of phencyclidine or amphetamine dependence.
    Tennant FS; Tarver A; Pumphrey E; Seecof R
    NIDA Res Monogr; 1986; 67():310-7. PubMed ID: 3092084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desipramine in the treatment of depressed alcoholics.
    Mason BJ; Kocsis JH
    Am J Psychiatry; 1994 Aug; 151(8):1248. PubMed ID: 8037266
    [No Abstract]   [Full Text] [Related]  

  • 15. Single- versus multiple-dose comparative trial of desipramine hydrochloride: a double-placebo method.
    Barnes RJ; Guarino RA
    J Clin Pharmacol; 1980; 20(11):681-8. PubMed ID: 7014655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of clomipramine and desipramine in the treatment of developmental stuttering.
    Gordon CT; Cotelingam GM; Stager S; Ludlow CL; Hamburger SD; Rapoport JL
    J Clin Psychiatry; 1995 Jun; 56(6):238-42. PubMed ID: 7775365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAMe versus placebo: a double blind comparison in major depressive disorders.
    Muscettola G; Galzenati M; Balbi A
    Adv Biochem Psychopharmacol; 1982; 32():151-6. PubMed ID: 7046362
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
    J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retreatment for relapse following desipramine discontinuation in dysthymia.
    Friedman RA; Mitchell J; Kocsis JH
    Am J Psychiatry; 1995 Jun; 152(6):926-8. PubMed ID: 7755126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression.
    Roth D; Mattes J; Sheehan KH; Sheehan DV
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):929-39. PubMed ID: 2126144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.